Discovery & Development

Find out how nanotechnology can overcome challenges in drug delivery to the eye.

We explore the potential of mRNA as therapeutics and the challenges associated with analysis and sequencing.

We sit down to interview Louise Modis, Chief Scientific Officer at Mogrify, UK, about her career and role at the company.

With so many new dosage forms being seen in pharma, a problem is emerging: the need for novel excipients. Watch our video to learn more.

How work on sharks could provide a highly effective weapon against new COVID variants

We find out more about the video game that won FDA approval as a treatment for children with ADHD

EsoCap CEO Isabelle Racamier tells the story behind a new drug delivery technology that could supplant syrups and pills for illnesses of the esophagus

We talk to a young excipient expert who won The Journal of Pharmaceutical Sciences’ 2021 Outstanding Early Career Scientists award.

A 2000-participant study in Europe has examined how drugs – and combinations of drugs – can affect the microbiota in our gut.

What can the Professor X of Heidelberg tell us about a new way of tackling cancer?